Orita Hiroshi, Shimogori Hiroaki, Yamashita Hiroshi
Department of Otolaryngology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.
Neurosci Lett. 2009 Jan 16;449(3):207-10. doi: 10.1016/j.neulet.2008.11.020. Epub 2008 Nov 13.
Previous studies have reported localization of substance P (SP) within the inner ear and that SP exists abundantly within vestibular endorgans. While SP's functional role in the inner ear remains unclear, SP can act as a neuromodulator in the CNS and directly influences neuronal excitability. We hypothesized that SP might influence neuronal excitability within the vestibular periphery. The present study used the sinusoidal rotation test to investigate the influence of SP after its local application in the guinea pig unilateral inner ear. A tiny hole was made adjacent to the round window in the right ears of Hartley white guinea pigs that had normal tympanic membranes and Preyer reflexes. An osmotic pump infused SP (10(-4)M, 10(-3)M, and 10(-2)M), neurokinin-1 (NK-1) receptor antagonist (10(-3)M) alone, or SP (10(-3)M)+NK-1 receptor antagonist (10(-3)M) through this hole, with rotation tests performed before, and 12h and 24h after the treatment. Results were used to calculate the vestibulo-ocular reflex (VOR) gains. After administration of 10(-3)M and 10(-2)M SP, significant increases in the VOR gains were noted at 12h after treatment, with these gains disappearing by 24h after treatment. This increase was not observed when there was simultaneous NK-1 receptor antagonist administration. There were also no changes in the VOR gains noted after administration of 10(-4)M SP or the NK-1 receptor antagonist alone. These results indicate the possibility that SP may act on vestibular endorgans as an excitatory factor via the NK-1 receptors.
先前的研究报告了P物质(SP)在内耳中的定位,并且SP在前庭终器中大量存在。虽然SP在内耳中的功能作用尚不清楚,但SP可在中枢神经系统中充当神经调节剂,并直接影响神经元兴奋性。我们假设SP可能会影响前庭外周的神经元兴奋性。本研究使用正弦旋转试验来研究SP局部应用于豚鼠单侧内耳后的影响。在鼓膜正常且有普赖尔反射的哈特利白色豚鼠的右耳圆窗附近开一个小孔。一个渗透泵通过这个小孔注入SP(10^(-4)M、10^(-3)M和10^(-2)M)、单独的神经激肽-1(NK-1)受体拮抗剂(10^(-3)M)或SP(10^(-3)M)+NK-1受体拮抗剂(10^(-3)M),在治疗前、治疗后12小时和24小时进行旋转试验。结果用于计算前庭眼反射(VOR)增益。给予10^(-3)M和10^(-2)M SP后,治疗后12小时VOR增益显著增加,这些增益在治疗后24小时消失。同时给予NK-1受体拮抗剂时未观察到这种增加。给予10^(-4)M SP或单独的NK-1受体拮抗剂后,VOR增益也没有变化。这些结果表明SP可能通过NK-1受体作为一种兴奋性因子作用于前庭终器。